Cargando…
Docking Study on Anti-HIV-1 Activity of Secondary Metabolites from Zingiberaceae Plants
INTRODUCTION: Human immunodeficiency virus type-1 (HIV-1) that causes acquired immunodeficiency syndrome (AIDS) has become a worldwide health problem today. There are approximately 30 anti-HIV-1 drugs that have been used in the treatment of AIDS. However, effective anti HIV-1 agents with less side a...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021037/ https://www.ncbi.nlm.nih.gov/pubmed/33828375 http://dx.doi.org/10.4103/jpbs.JPBS_261_19 |
_version_ | 1783674672617881600 |
---|---|
author | Zubair, Muhammad Sulaiman Maulana, Saipul Widodo, Agustinus Mukaddas, Alwiyah Pitopang, Ramadanil |
author_facet | Zubair, Muhammad Sulaiman Maulana, Saipul Widodo, Agustinus Mukaddas, Alwiyah Pitopang, Ramadanil |
author_sort | Zubair, Muhammad Sulaiman |
collection | PubMed |
description | INTRODUCTION: Human immunodeficiency virus type-1 (HIV-1) that causes acquired immunodeficiency syndrome (AIDS) has become a worldwide health problem today. There are approximately 30 anti-HIV-1 drugs that have been used in the treatment of AIDS. However, effective anti HIV-1 agents with less side affect and high inhibition potency are still in demand. OBJECTIVE: The objective of this study was to identify the potential compounds from Zingiberaceae plants that might be active as anti-HIV-1 by molecular docking. MATERIALS AND METHODS: Molecular docking simulation was performed by using AutoDock 4.2 on Linux operation system. Docking protocol was validated by using root mean square deviation (RMSD) value using redocking and cross-docking methods. The reported metabolites from Zingiberaceae plants were docked on HIV-1 protease, integrase, and reverse transcriptase protein enzymes. RESULTS: The docking result showed that the genera of Zingiber, Etlingera, Alpinia, Hedychium, and Boesenbergia have potential metabolites that inhibit HIV protease, integrase, and reverse transcriptase enzymes by possessing lower docking energy than native ligand of amprenavir, raltegravir, and nevirapine. Among the metabolites, noralpindenoside B and alpindenoside A from Alpinia densespicata inhibited protease enzymes with the lowest docking energy of -18.02 and -17.90 kcal/mol, respectively. Meanwhile, panduratin E from Boesenbergia pandurata Roxb. and 5α,8α-epidioxyergosta-6,22-dien-3β-ol from Etlingera elatior showed the lowest docking energy on integrase protein with docking energy of -11.97 and -11.41 kcal/mol, respectively. Pahangensin A from Alpinia pahangensis Ridley showed the lowest docking energy on reverse transcriptase enzyme with docking energy of -13.76 kcal/mol. CONCLUSION: The docking molecular study has identified the possible potential compounds from Zingiberaceae plants that might be used for anti-HIV-1 treatment. So, this study suggested further isolation and purification of the predicted compounds. |
format | Online Article Text |
id | pubmed-8021037 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-80210372021-04-06 Docking Study on Anti-HIV-1 Activity of Secondary Metabolites from Zingiberaceae Plants Zubair, Muhammad Sulaiman Maulana, Saipul Widodo, Agustinus Mukaddas, Alwiyah Pitopang, Ramadanil J Pharm Bioallied Sci Original Article INTRODUCTION: Human immunodeficiency virus type-1 (HIV-1) that causes acquired immunodeficiency syndrome (AIDS) has become a worldwide health problem today. There are approximately 30 anti-HIV-1 drugs that have been used in the treatment of AIDS. However, effective anti HIV-1 agents with less side affect and high inhibition potency are still in demand. OBJECTIVE: The objective of this study was to identify the potential compounds from Zingiberaceae plants that might be active as anti-HIV-1 by molecular docking. MATERIALS AND METHODS: Molecular docking simulation was performed by using AutoDock 4.2 on Linux operation system. Docking protocol was validated by using root mean square deviation (RMSD) value using redocking and cross-docking methods. The reported metabolites from Zingiberaceae plants were docked on HIV-1 protease, integrase, and reverse transcriptase protein enzymes. RESULTS: The docking result showed that the genera of Zingiber, Etlingera, Alpinia, Hedychium, and Boesenbergia have potential metabolites that inhibit HIV protease, integrase, and reverse transcriptase enzymes by possessing lower docking energy than native ligand of amprenavir, raltegravir, and nevirapine. Among the metabolites, noralpindenoside B and alpindenoside A from Alpinia densespicata inhibited protease enzymes with the lowest docking energy of -18.02 and -17.90 kcal/mol, respectively. Meanwhile, panduratin E from Boesenbergia pandurata Roxb. and 5α,8α-epidioxyergosta-6,22-dien-3β-ol from Etlingera elatior showed the lowest docking energy on integrase protein with docking energy of -11.97 and -11.41 kcal/mol, respectively. Pahangensin A from Alpinia pahangensis Ridley showed the lowest docking energy on reverse transcriptase enzyme with docking energy of -13.76 kcal/mol. CONCLUSION: The docking molecular study has identified the possible potential compounds from Zingiberaceae plants that might be used for anti-HIV-1 treatment. So, this study suggested further isolation and purification of the predicted compounds. Wolters Kluwer - Medknow 2020-11 2020-11-05 /pmc/articles/PMC8021037/ /pubmed/33828375 http://dx.doi.org/10.4103/jpbs.JPBS_261_19 Text en Copyright: © 2020 Journal of Pharmacy and Bioallied Sciences http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Zubair, Muhammad Sulaiman Maulana, Saipul Widodo, Agustinus Mukaddas, Alwiyah Pitopang, Ramadanil Docking Study on Anti-HIV-1 Activity of Secondary Metabolites from Zingiberaceae Plants |
title | Docking Study on Anti-HIV-1 Activity of Secondary Metabolites from Zingiberaceae Plants |
title_full | Docking Study on Anti-HIV-1 Activity of Secondary Metabolites from Zingiberaceae Plants |
title_fullStr | Docking Study on Anti-HIV-1 Activity of Secondary Metabolites from Zingiberaceae Plants |
title_full_unstemmed | Docking Study on Anti-HIV-1 Activity of Secondary Metabolites from Zingiberaceae Plants |
title_short | Docking Study on Anti-HIV-1 Activity of Secondary Metabolites from Zingiberaceae Plants |
title_sort | docking study on anti-hiv-1 activity of secondary metabolites from zingiberaceae plants |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021037/ https://www.ncbi.nlm.nih.gov/pubmed/33828375 http://dx.doi.org/10.4103/jpbs.JPBS_261_19 |
work_keys_str_mv | AT zubairmuhammadsulaiman dockingstudyonantihiv1activityofsecondarymetabolitesfromzingiberaceaeplants AT maulanasaipul dockingstudyonantihiv1activityofsecondarymetabolitesfromzingiberaceaeplants AT widodoagustinus dockingstudyonantihiv1activityofsecondarymetabolitesfromzingiberaceaeplants AT mukaddasalwiyah dockingstudyonantihiv1activityofsecondarymetabolitesfromzingiberaceaeplants AT pitopangramadanil dockingstudyonantihiv1activityofsecondarymetabolitesfromzingiberaceaeplants |